2010
DOI: 10.1002/eji.200939883
|View full text |Cite
|
Sign up to set email alerts
|

Increased IL‐17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model

Abstract: Autoimmune polyendocrine syndrome type 1 (APS-1) is a multiorgan autoimmune disease caused by mutations in the autoimmune regulator (AIRE) gene. Chronic mucocutaneous candidiasis, hypoparathyroidism and adrenal failure are hallmarks of the disease. The critical mechanisms causing chronic mucocutaneous candidiasis in APS-1 patients have not been identified although autoantibodies to cytokines are implicated in the pathogenesis. To investigate whether the Th reactivity to Candida albicans (C. albicans) and other… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
36
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 41 publications
(38 citation statements)
references
References 33 publications
2
36
0
Order By: Relevance
“…8). Considering that IL-17 expression is differentially regulated by different pathogens in the same cell [44], our conclusions concerning C. albicans may not be transferable to infection of other pathogens. To address these concerns, we are currently undertaking comparative studies with other pathogens.…”
Section: Discussionmentioning
confidence: 74%
“…8). Considering that IL-17 expression is differentially regulated by different pathogens in the same cell [44], our conclusions concerning C. albicans may not be transferable to infection of other pathogens. To address these concerns, we are currently undertaking comparative studies with other pathogens.…”
Section: Discussionmentioning
confidence: 74%
“…More recently, autoantibodies against the Th17-related cytokines (IL-22, IL-17F, and IL-17A) were identified in APECED patients [29,69]. These autoantibodies are very specific, highly prevalent, neutralizing and develop very early during the disease course [29,69,80,131]. Autoantibodies to IL-22 in APECED patients appear within the first months of life, similar to those against type I IFNs [22,69].…”
Section: Autoantibodies and Their Diagnostic And Prognostic Value In mentioning
confidence: 88%
“…Additionally, IL-22 promotes epithelial barrier integrity, especially in synergy with TNF-α co-secreted by Th22 cells [76,77]. In contrast to several other syndromes associated with CMC [78,79], the circulating lymphocytes of APECED patients produce normal or even increased amounts of IL-17A [80,81], but are deficient in IL-22 and IL-17F secretion [69,80,81]. Moreover, the production of IL-22 is severely impaired by the skin-populating T cells of APECED patients [82].…”
Section: Chronic Mucocutaneous Candidiasismentioning
confidence: 97%
“…The role of IL-17A secretion seems somewhat controversial in these studies. One of them found increased numbers of C. albicans-induced IL-17A-producing cells in PBMC from APECED patients, measured by flow cytometry by intracellular staining of IL-17A [1], in contrast with other studies, which consistently found impaired IL-17A responses in APECED patients [8,11,23]. PBMCs from our patients released small amounts of IL-17A and much smaller, or negligible amounts of IL-17F and IL-22 by Candidaexposed cells, compared with healthy controls.…”
Section: Discussionmentioning
confidence: 99%